Isometric Exercise for Delayed Onset Muscle Soreness
30. Mai 2026 aktualisiert von: Onur Atakan Sekibağ, Istanbul Nisantasi University
Effects of Isometric Exercise on Recovery Following Experimentally Induced Delayed Onset Muscle Soreness: A Randomized Controlled Trial
The goal of this clinical trial is to learn whether isometric exercise can improve recovery following experimentally induced delayed onset muscle soreness (DOMS) in healthy young adults.
The main questions it aims to answer are:
- Does isometric exercise reduce pain associated with delayed onset muscle soreness?
- Does isometric exercise improve pressure pain threshold, knee joint range of motion, muscle strength, and recovery following delayed onset muscle soreness?
Researchers will compare participants performing an isometric exercise program with a control group receiving no intervention to determine whether isometric exercise improves recovery after experimentally induced DOMS.
Participants will:
- Undergo a standardized exercise protocol to induce delayed onset muscle soreness.
- Be randomly assigned to either an isometric exercise group or a control group.
- Complete assessments of pain intensity, pressure pain threshold, knee range of motion, muscle strength, and thigh circumference.
- Be evaluated before exercise, immediately after exercise, and on Days 1, 3, and 5 following DOMS induction.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Delayed onset muscle soreness (DOMS) is a common consequence of unaccustomed or high-intensity physical activity, particularly exercises involving eccentric muscle contractions. DOMS is characterized by pain, tenderness, temporary reductions in muscle function, decreased range of motion, and impaired physical performance, typically peaking between 24 and 72 hours after exercise.
Various recovery strategies have been investigated to reduce the symptoms of DOMS; however, evidence regarding the effectiveness of isometric exercise in facilitating recovery remains limited. Previous studies have suggested that isometric muscle contractions may induce analgesic effects and increase pressure pain thresholds in musculoskeletal conditions. Whether these effects can improve recovery following exercise-induced muscle damage and DOMS has not been fully established.
The purpose of this randomized controlled trial was to investigate the effects of an isometric exercise program on recovery following experimentally induced DOMS in healthy adults. DOMS was induced using a standardized drop-jump protocol. Participants were randomly assigned to either an isometric exercise group or a control group. Outcome assessments were performed before DOMS induction, immediately after exercise, and during follow-up evaluations on Days 1, 3, and 5.
The findings of this study may contribute to the understanding of the role of isometric exercise as a simple, low-cost, and clinically applicable recovery strategy following exercise-induced muscle soreness.
Studientyp
Interventionell
Einschreibung (Tatsächlich)
40
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
Maslak
-
Istanbul, Maslak, Türkei (türkiye), 34398
- Istanbul Nisantasi University
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Ja
Beschreibung
Inclusion Criteria:
- Active athletes competing in University sports teams.
- Age between 18 and 30 years.
- Participation in organized sports training at least three times per week for the previous six months.
- No lower-extremity pain at the time of enrollment.
- Ability to safely perform the exercise protocol used to induce delayed onset muscle soreness (DOMS).
- Willingness to provide written informed consent.
Exclusion Criteria:
- History of lower-extremity musculoskeletal injury within the previous 6 months.
- Previous lower-extremity surgery.
- Current musculoskeletal pain or injury affecting sports participation.
- Neurological, rheumatological, cardiovascular, or systemic disorders affecting physical performance.
- Use of analgesic, anti-inflammatory, or muscle-relaxant medications during the study period.
- Participation in strenuous eccentric exercise within 72 hours prior to baseline testing.
- Use of recovery interventions (e.g., massage, cryotherapy, compression garments, electrical stimulation) during the study period.
- Inability to complete the exercise protocol or follow-up assessments.
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Isometric Exercise Group
Participants in this group underwent a standardized protocol to induce delayed onset muscle soreness (DOMS) and subsequently performed a structured quadriceps isometric exercise program during the recovery period.
|
Participants performed a structured quadriceps isometric exercise program following experimentally induced delayed onset muscle soreness.
The exercise protocol was applied according to the study protocol throughout the recovery period.
|
|
Schein-Komparator: Sham Exercise Group
Participants performed a sham exercise protocol following experimentally induced delayed onset muscle soreness.
The sham intervention was designed to mimic the attention and participation associated with the experimental intervention without providing the intended therapeutic effect.
|
Participants performed a sham exercise protocol following experimentally induced delayed onset muscle soreness.
The sham intervention was designed to mimic the attention and participation associated with the experimental intervention without providing the intended therapeutic effect.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Pressure Pain Threshold
Zeitfenster: Baseline, immediately after exercise, Day 1, Day 3, and Day 5 following DOMS induction.
|
Pressure pain threshold measured using a digital pressure algometer following experimentally induced delayed onset muscle soreness (DOMS).
|
Baseline, immediately after exercise, Day 1, Day 3, and Day 5 following DOMS induction.
|
|
Pain Intensity
Zeitfenster: Baseline, immediately after exercise, Day 1, Day 3, and Day 5 following DOMS induction.
|
Pain intensity assessed using a 10-cm Visual Analog Scale (VAS) following experimentally induced delayed onset muscle soreness (DOMS).
|
Baseline, immediately after exercise, Day 1, Day 3, and Day 5 following DOMS induction.
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Knee Joint Range of Motion
Zeitfenster: Baseline, immediately after exercise, Day 1, Day 3, and Day 5 following DOMS induction.
|
Knee joint range of motion measured using a standard goniometer.
|
Baseline, immediately after exercise, Day 1, Day 3, and Day 5 following DOMS induction.
|
|
Quadriceps Muscle Strength
Zeitfenster: Baseline, immediately after exercise, Day 1, Day 3, and Day 5 following DOMS induction.
|
Quadriceps muscle strength measured using a handheld dynamometer.
|
Baseline, immediately after exercise, Day 1, Day 3, and Day 5 following DOMS induction.
|
|
Thigh Circumference
Zeitfenster: Baseline, immediately after exercise, Day 1, Day 3, and Day 5 following DOMS induction.
|
Thigh circumference measured using a tape measure to assess exercise-induced swelling.
|
Baseline, immediately after exercise, Day 1, Day 3, and Day 5 following DOMS induction.
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Publikationen und hilfreiche Links
Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.
Allgemeine Veröffentlichungen
- Rio E, Kidgell D, Purdam C, Gaida J, Moseley GL, Pearce AJ, Cook J. Isometric exercise induces analgesia and reduces inhibition in patellar tendinopathy. Br J Sports Med. 2015 Oct;49(19):1277-83. doi: 10.1136/bjsports-2014-094386. Epub 2015 May 15.
- Di Lorenzo L, Forte AM, Agosti V, Forte F, Lanciano T, Pirraglia N, D'Avanzo C. Advances in Non-Pharmacological Strategies for DOMS: A Scoping and Critical Review of Recent Evidence. J Funct Morphol Kinesiol. 2025 Nov 20;10(4):452. doi: 10.3390/jfmk10040452.
- de Morais ACL, Machado AS, Pereira MEF, da Silva W, Priego-Quesada JI, Carpes FP. Intensity and volume of physical exercise influence DOMS and skin temperature differently in healthy adults. Sci Rep. 2024 Dec 5;14(1):30282. doi: 10.1038/s41598-024-79785-2.
- Rio E, van Ark M, Docking S, Moseley GL, Kidgell D, Gaida JE, van den Akker-Scheek I, Zwerver J, Cook J. Isometric Contractions Are More Analgesic Than Isotonic Contractions for Patellar Tendon Pain: An In-Season Randomized Clinical Trial. Clin J Sport Med. 2017 May;27(3):253-259. doi: 10.1097/JSM.0000000000000364.
- Fleckenstein J, Simon P, Konig M, Vogt L, Banzer W. The pain threshold of high-threshold mechanosensitive receptors subsequent to maximal eccentric exercise is a potential marker in the prediction of DOMS associated impairment. PLoS One. 2017 Oct 6;12(10):e0185463. doi: 10.1371/journal.pone.0185463. eCollection 2017.
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
1. April 2025
Primärer Abschluss (Tatsächlich)
18. Juli 2025
Studienabschluss (Tatsächlich)
18. Juli 2025
Studienanmeldedaten
Zuerst eingereicht
30. Mai 2026
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
30. Mai 2026
Zuerst gepostet (Tatsächlich)
4. Juni 2026
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
4. Juni 2026
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
30. Mai 2026
Zuletzt verifiziert
1. Mai 2026
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- OASIsometricDOMS
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
JA
Beschreibung des IPD-Plans
De-identified individual participant data underlying the published results may be made available upon reasonable request to the corresponding author, subject to institutional approval and applicable ethical requirements.
IPD-Sharing-Zeitrahmen
De-identified individual participant data, study protocol, statistical analysis plan, and analytic code will be available beginning 6 months after publication of the primary study results and ending 5 years after publication.
IPD-Sharing-Zugriffskriterien
De-identified individual participant data and supporting documents will be made available to qualified researchers upon reasonable request.
Requests must include a methodologically sound research proposal and will be reviewed by the study investigators.
Data will be provided after approval of the request and completion of an appropriate data-sharing agreement.
Access will be limited to data necessary to achieve the approved research objectives.
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
- SAFT
- ANALYTIC_CODE
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .